Ziltivekimab
EX6018-4915
Phase 3 small_molecule active
Quick answer
Ziltivekimab for Heart Failure is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Heart Failure
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active